Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bull Exp Biol Med ; 175(5): 644-648, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37861908

RESUMEN

For antibody-based drugs, it is important and relevant to study their toxic effects, which can often become limiting when prescribing this type of therapy. General toxicity of antiviral drug Ergoferon based on technologically processed antibodies was studied on sexually mature animals. Analysis of acute toxicity showed the absence of lethal outcomes when the drug was administered to adult rats at the maximum tolerated doses. In a study of repeated dose toxicity, no adverse effects of the drug were detected.


Asunto(s)
Anticuerpos , Antivirales , Ratas , Animales , Antivirales/farmacología , Anticuerpos/farmacología , Pruebas de Toxicidad Aguda
2.
Bull Exp Biol Med ; 176(2): 176-180, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38191875

RESUMEN

General toxic effect of the drug Prospekta (modified affinity purified antibodies to the brain-specific S100 protein) was studied on mature male and female mice and rats: acute toxicity with double intragastric and intraperitoneal administration of the maximum permissible doses at a 2-h interval, repeated dose toxicity with intragastric administration of the maximum permissible and close to therapeutic doses for 6 months. No lethal and toxic effects on animals were observed, including no toxic effects on vital systems, i.e., CNS and cardiovascular system, as well systems with the functions that may be temporarily disrupted (excretory and digestive systems). All the differences between animals of the experimental and control groups varied within the physiological range. It can be concluded that the drug produces no general toxic effect on laboratory animals.


Asunto(s)
Preparaciones Farmacéuticas , Ratas , Ratones , Masculino , Femenino , Animales , Dosificación Letal Mediana
3.
Bull Exp Biol Med ; 169(1): 57-59, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32488783

RESUMEN

The effects of a new derivative of benzimidazole (K-134) in doses of 5 and 50 mg/kg on the spermatogenesis and fertilizing ability of spermatozoa were studied on male rats. It was found that 2-month course treatment with the studied substance enhances the producing ability of the spermatogenic epithelium and improves fertilizing ability of spermatozoa.


Asunto(s)
Fertilidad/efectos de los fármacos , Quinolinas/farmacología , Epitelio Seminífero/efectos de los fármacos , Urea/análogos & derivados , Animales , Animales no Consanguíneos , Bencimidazoles/farmacología , Citoprotección/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Masculino , Ratas , Epitelio Seminífero/fisiología , Espermatogénesis/efectos de los fármacos , Testículo/efectos de los fármacos , Urea/farmacología
4.
Bull Exp Biol Med ; 162(4): 441-444, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28239784

RESUMEN

Physical development, development of sensory and motor reflexes, behavioral and mnestic patterns were studied infantile and juvenile rat pups born by female rats receiving Afobazole during pregnancy. Physical development and development of sensory and motor reflexes in rats were completed without pathologies by the age of 2 months. During the infantile period, the rat pups demonstrated reduced body weight gain, delayed eye opening and pupillary response formation, decreased muscle force, and suppressed motor behavior. During the juvenile period, body weight gain and development of motor behavior were intensified. Females demonstrated later vagina opening and poorer mnestic responses. In males, the terms of sexual maturation were unchanged and processes of learning and memory retrieval were not impaired.


Asunto(s)
Ansiolíticos/efectos adversos , Bencimidazoles/efectos adversos , Exposición Materna/efectos adversos , Morfolinas/efectos adversos , Efectos Tardíos de la Exposición Prenatal/etiología , Animales , Animales Recién Nacidos , Reacción de Prevención/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Femenino , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Fuerza Muscular/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/crecimiento & desarrollo , Embarazo , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Ratas , Reflejo Pupilar/efectos de los fármacos , Maduración Sexual/efectos de los fármacos , Aumento de Peso/efectos de los fármacos
5.
Eksp Klin Farmakol ; 80(1): 28-31, 2017.
Artículo en Ruso | MEDLINE | ID: mdl-29874000

RESUMEN

It is experimentally established that afobazole produces no damaging action on the organogenesis and fetogenic processes registered in the postnatal period of rat offspring development. It was noted that, in rat babies in lactation age, the dynamics of body weight gain was lower on average by 7.4% (p < 0.05) in males and 17.0% (p < 0.001) in females; the rate of muscular force maturing was lower by 2.7% (p < 0.05); and the locomotive activity was lower (by 19.4% for ver- tical standings and by 50% for looking into floor holes, p < 0.05) compared to control values. For the same offspring passed to definitive food, the body weight gain and behavioral activity did not differ from control indicators, while the terms of sexual development were delayed in females and did not change in males. By two-month age, the physical development of rat offspring was completely created and met physiological standards.


Asunto(s)
Ansiolíticos/farmacología , Conducta Animal/efectos de los fármacos , Bencimidazoles/farmacología , Lactancia/efectos de los fármacos , Morfolinas/farmacología , Actividad Motora/efectos de los fármacos , Animales , Animales Recién Nacidos , Femenino , Lactancia/fisiología , Masculino , Embarazo , Efectos Tardíos de la Exposición Prenatal/diagnóstico , Efectos Tardíos de la Exposición Prenatal/patología , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Factores Sexuales
6.
Bull Exp Biol Med ; 161(2): 252-6, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27383169

RESUMEN

We studied chronic toxicity of a few release-active preparations: Dietressa (release-active preparation of affinity-purified antibodies to type 1 cannabinoid receptor), Divasa (releaseactive preparation containing a combination of affinity-purified antibodies to brain-specific S-100 protein and endothelial NO-synthase), Cardostin (release-active preparation containing a combination of affinity-purified antibodies to C-terminal fragment of angiotensin II type 1 receptor and endothelial NO-synthase), and Bation (release-active preparation containing a combination of affinity-purified antibodies to IFN-γ and CD4). We evaluated not only side and toxic effects, but also the relationships between these effects and pharmacological activities of the preparations. The data of preclinical toxicological studies of the release-active preparations can be used for prediction of their pharmacological activity.


Asunto(s)
Anticuerpos/farmacología , Depresores del Apetito/farmacología , Animales , Peso Corporal/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Femenino , Masculino , Actividad Motora/efectos de los fármacos , Ratas
7.
Eksp Klin Farmakol ; 79(9): 25-28, 2016.
Artículo en Ruso | MEDLINE | ID: mdl-29787668

RESUMEN

Experiments on pregnant female rats showed that the beta-phenylglutaminic acid hydrochloride derivative neuroglutam (glutaron), exhibiting antidepressant and anxiolytic activity upon intragastric administration in doses of 26, 130 and 650 mg/kg to female rats from 6 to 16 days of pregnancy, does not impair organo- and fetogenesis processes (developments of fetus) registered during the anthenatal period, decreases fetal death, and activates the processes of prenatal development of the fetus bv 11.1% (p < 0.001), 8.3% (p < 0.001), and 2.8% (p < 0.05), respectively.


Asunto(s)
Antidepresivos/farmacología , Desarrollo Fetal/efectos de los fármacos , Organogénesis/efectos de los fármacos , Animales , Femenino , Embarazo , Ratas
8.
Bull Exp Biol Med ; 159(5): 629-31, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26468027

RESUMEN

The effects of impaza on ovulatory cycles, sexual behavior, and conception processes were studied in female rats. A two-week course of impaza in doses of 3 and 15 ml/kg did not affect alternation of estrous cycle phases, the incidence of estrus reducing. Sexual behavior of these females was characterized by activation of the receptive sexual motivations; conception was characterized by a higher fertility index and a lower fetal mortality.


Asunto(s)
Anticuerpos/farmacología , Ciclo Estral/efectos de los fármacos , Fármacos para la Fertilidad Femenina/farmacología , Fertilización/efectos de los fármacos , Aptitud Genética/efectos de los fármacos , Conducta Sexual Animal/efectos de los fármacos , Animales , Animales no Consanguíneos , Ciclo Estral/fisiología , Femenino , Fertilización/fisiología , Mortalidad Fetal , Aptitud Genética/fisiología , Libido/efectos de los fármacos , Tamaño de la Camada/efectos de los fármacos , Tamaño de la Camada/fisiología , Masculino , Embarazo , Ratas , Conducta Sexual Animal/fisiología
9.
Bull Exp Biol Med ; 159(5): 635-7, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26468030

RESUMEN

The effects of a new thietanylbenzimidazole derivative (K-134) on estrous cycles, conception processes, and sexual behavior of female rats were studied. Two-week oral treatment with K-134 in doses of 5 and 50 mg/kg shortened the estrus phase and prolonged proestrus. Changes in sexual behavior were presented by activation of receptive sexual motivations without affecting proceptive motivations. The pregnancy and fertility indexes in experimental females after mating with intact males increased and pre- and postimplantation embryonic death decreased.


Asunto(s)
Bencimidazoles/farmacología , Ciclo Estral/efectos de los fármacos , Fármacos para la Fertilidad Femenina/farmacología , Fertilización/efectos de los fármacos , Aptitud Genética/efectos de los fármacos , Conducta Sexual Animal/efectos de los fármacos , Animales , Animales no Consanguíneos , Ciclo Estral/fisiología , Femenino , Fertilización/fisiología , Mortalidad Fetal , Aptitud Genética/fisiología , Libido/efectos de los fármacos , Tamaño de la Camada/efectos de los fármacos , Tamaño de la Camada/fisiología , Masculino , Embarazo , Ratas , Conducta Sexual Animal/fisiología
10.
Bull Exp Biol Med ; 157(1): 37-41, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24915946

RESUMEN

We studied the efficiency of Dietressa on body weight reduction in C57Bl/6 male mice feeding standard high-fat ration (24%). After 5-month daily intragastric administration of Dietressa, body weight gain was the lowest in comparison with other groups and did not differ from that in mice receiving the reference substance sibutramine for 5 months. In contrast to sibutramine, Dietressa did not increase motor activity of animals in the open field test and produced no anorectic effect. The mean body weight gain per each 1000 kcal of consumed food in the group of animals receiving Dietressa was lower than in the control group and mice receiving sibutramine.


Asunto(s)
Fármacos Antiobesidad/farmacología , Anticuerpos/farmacología , Antagonistas de Receptores de Cannabinoides/farmacología , Obesidad/tratamiento farmacológico , Pérdida de Peso/efectos de los fármacos , Animales , Depresores del Apetito/farmacología , Ciclobutanos/farmacología , Dieta Alta en Grasa , Grasas de la Dieta/efectos adversos , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/etiología , Obesidad/fisiopatología , Receptor Cannabinoide CB1/antagonistas & inhibidores , Receptor Cannabinoide CB1/metabolismo
11.
Bull Exp Biol Med ; 152(3): 321-4, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22803076

RESUMEN

The capacity of a new drug containing ultra-low doses of antibodies to cannabinoid receptor type 1 (Dietressa) to reduce body weight gain in mice on a high-calorie diet was evaluated, possible mechanisms of drug action were analyzed, and its safety (abuse potential in the reaction of self-stimulation) was evaluated. Dietressa was not inferior to sibutramine in reducing body weight gain in mice and exhibited no abuse potential.


Asunto(s)
Fármacos Antiobesidad/farmacología , Anticuerpos/farmacología , Obesidad/prevención & control , Receptor Cannabinoide CB1/inmunología , Pérdida de Peso/efectos de los fármacos , Animales , Ciclobutanos/metabolismo , Ciclobutanos/farmacología , Evaluación Preclínica de Medicamentos , Ingestión de Alimentos/efectos de los fármacos , Ingestión de Alimentos/fisiología , Masculino , Ratones
12.
Eksp Klin Farmakol ; 75(4): 23-5, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-22702107

RESUMEN

Positive effects of ladasten on both antenatal and postnatal development have been established in experiments on pregnant female rats. Under the action of this drug, the number of resorption events decreases and process of antenatal development of fetuses is activated. In the postnatal period, increased weight gain and accelerated physical development has been observed in the progeny of rats treated with ladasten.


Asunto(s)
Adamantano/análogos & derivados , Desarrollo Fetal/efectos de los fármacos , Aumento de Peso/efectos de los fármacos , Adamantano/administración & dosificación , Animales , Femenino , Embarazo , Ratas
13.
Eksp Klin Farmakol ; 75(12): 27-9, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-23700665

RESUMEN

The effects of kardostin on the ovulatory cycle, conception, and sexual behavior of female rats have been experimentally studied. It is established that a two-week therapy with kardostin at a dose of 5 and 15 mg/kg changed phases of the estrous cycle (with the estrus phase being most prevalent) and led to ambiguous changes in the sexual behavior of female rats (a dose of 5 mg/kg increased sexual behavior, while a dose of 15 mg/kg inhibited it), activated fertility, and improved the quality of conception.


Asunto(s)
Bloqueadores del Receptor Tipo 2 de Angiotensina II/farmacología , Anticuerpos Monoclonales/farmacología , Fertilidad/efectos de los fármacos , Fertilización/efectos de los fármacos , Conducta Sexual Animal/efectos de los fármacos , Animales , Ciclo Estral/efectos de los fármacos , Femenino , Masculino , Ciclo Menstrual/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo III/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo III/metabolismo , Embarazo , Ratas , Receptor de Angiotensina Tipo 2/metabolismo
14.
Bull Exp Biol Med ; 150(2): 215-8, 2010 Dec.
Artículo en Inglés, Ruso | MEDLINE | ID: mdl-21240376
15.
Eksp Klin Farmakol ; 73(10): 31-3, 2010 Oct.
Artículo en Ruso | MEDLINE | ID: mdl-21254511

RESUMEN

Toxicological experiments showed that the new benzimidazole derivative with hypoglycemic action--diabenol--influences the sexual activity and processes of female fertilization. The estrous cycle, sexual activity and quality of fertilization were activated at females upon the administration of diabenol in a therapeutic dose of 5 mg/kg. It is established that the drug administration in a toxic dose of 160 mg/kg suppresses the sexual activity and, at the same time, does not affect the estrous cycle and quality of fertilization in females.


Asunto(s)
Bencimidazoles/efectos adversos , Ciclo Estral/efectos de los fármacos , Fertilización/efectos de los fármacos , Hipoglucemiantes/efectos adversos , Conducta Sexual Animal/efectos de los fármacos , Animales , Bencimidazoles/farmacología , Relación Dosis-Respuesta a Droga , Femenino , Hipoglucemiantes/farmacología , Masculino , Ratas
16.
Eksp Klin Farmakol ; 70(4): 35-8, 2007.
Artículo en Ruso | MEDLINE | ID: mdl-18078041

RESUMEN

A standard solution of mineral bischofit has low toxicity and produces a dose-dependent effect on the antenatal development of rat fetuses. Bischofit in a dose of 0.01 ml/kg and 0.1 ml/kg (daily requirement for magnesium ions) increased the index of fertility and the quality of embryonal development in rats. The index of fertility was reduced and fetal skeleton formation was inhibited after the administration of bischofit in a dose of 1.0 ml/kg.


Asunto(s)
Desarrollo Fetal/efectos de los fármacos , Feto/efectos de los fármacos , Cloruro de Magnesio/toxicidad , Osteogénesis/efectos de los fármacos , Animales , Femenino , Masculino , Ratas , Ratas Endogámicas , Reproducción/efectos de los fármacos , Soluciones
17.
Eksp Klin Farmakol ; 70(2): 37-9, 2007.
Artículo en Ruso | MEDLINE | ID: mdl-17523449

RESUMEN

The ambiguous influence of bendazol (5 and 160 mg/kg) on the sexual behavior and spermatogenesis of rats was observed in experiments on male rats. An increase in the duration of sexual activity and a decrease of the total amount of spermatozoons were registered irrespective of the course of drug administration in a dose of 5 mg/kg. In males treated with bendazol in a dose of 160 mg/kg, the behavior varied depending on the duration of treatment: the sexual activity decreased upon a 5-day treatment and increased after a 2-month course. The index of spermatogenesis did not depend on the time of administration at 5 or 160 mg/kg, while the spermatozoon mobility was suppressed upon the short-term treatment and increased upon the log-term administration of bendazol.


Asunto(s)
Bencimidazoles/efectos adversos , Conducta Sexual Animal/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Ratas , Espermatozoides/efectos de los fármacos , Espermatozoides/fisiología
18.
Eksp Klin Farmakol ; 70(1): 40-3, 2007.
Artículo en Ruso | MEDLINE | ID: mdl-17402591

RESUMEN

The daily administration of bemithyl (20 mg/kg) from 6 th to 16 th day of pregnancy in female rats led to the decrease in fetal death after the implantation and increased fetal body weight. The treatment of pregnant rats also led to acceleration of the development of physical condition and sensomotor reflexes of progeny in the postnatal period.


Asunto(s)
Antioxidantes/farmacología , Bencimidazoles/farmacología , Feto/efectos de los fármacos , Placenta/metabolismo , Animales , Antioxidantes/metabolismo , Conducta Animal/efectos de los fármacos , Bencimidazoles/metabolismo , Femenino , Desarrollo Fetal/efectos de los fármacos , Embarazo , Ratas , Ratas Endogámicas
19.
Eksp Klin Farmakol ; 69(1): 38-41, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-16579058

RESUMEN

Bemithyl produced different influence on the sexual behavior (pairing motivation) and spermatogenesis in rats, depending on the dose and duration of drug administration. A three-day administration of bemithyl (20 and 200 mg/kg, p.o.) stimulated the sexual activity and spermatogenesis in male rats irrespective of the drug dose. The chronic administration of bemithyl over a period of 60 days led to a decrease in the male sexual activity and spermatogenesis index. This behavior can be related to the drug influence on the hypothalamus/pituitary structures responsible for the male rat generative function.


Asunto(s)
Bencimidazoles/farmacología , Estimulantes del Sistema Nervioso Central/farmacología , Conducta Sexual Animal/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Administración Oral , Animales , Bencimidazoles/administración & dosificación , Estimulantes del Sistema Nervioso Central/administración & dosificación , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Ratas
20.
Eksp Klin Farmakol ; 68(2): 28-32, 2005.
Artículo en Ruso | MEDLINE | ID: mdl-15934363

RESUMEN

Female rats were treated with bemithyl (20 and 100 mg/kg) via a gastric tube during a 16-day period of lactation. It was found that the drug is transferred with breast milk to the organism of newborns, which leads to nonuniformities in their development. Among the early effects of bemithyl, most pronounced is the stimulating action upon maturation (muscle strength) and the development of sensor-locomotor reflexes; in the spectrum of long-term effects, the drug influence upon pubescence processes was manifested.


Asunto(s)
Anticonvulsivantes/efectos adversos , Bencimidazoles/efectos adversos , Lactancia , Maduración Sexual/efectos de los fármacos , Administración Oral , Animales , Animales Recién Nacidos , Anticonvulsivantes/administración & dosificación , Bencimidazoles/administración & dosificación , Femenino , Lactancia/efectos de los fármacos , Masculino , Ratas , Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA